Leveraging Family Office Networks for Strategic Growth
Discover how Family Office Networks can enhance collaboration and investment opportunities.

Orange Grove Bio (“OGB”) is a preclinical drug development platform focused on driving down the cost of drug discovery and advancing therapies into clinical trials.
They are partnered with leading universities to license transformational medicines. Orange Grove Bio and its university partners streamline the licensing process to speed up the development process to get drugs to market faster and to save time on-patent.

Discover how Family Office Networks can enhance collaboration and investment opportunities.

Join the Family Office Networks Webinar Series Featuring Hemptown USA. Eric Gripentrog, CEO will discuss hemp derived cannabinoids, including CBD and CBG,…

Come Join the Family Office Networks’ Webinar Series featuring Asalyxa Bio. Asalyxa Bio’s elegant technology platform enables targeted delivery of therapeutic compounds…
Protected by reCAPTCHA — the Google Privacy Policy and Terms of Service apply.